# Effect of Acid Suppression Medication on Pediatric Microbiome

> **NCT02016820** · NA · TERMINATED · sponsor: **Columbia University** · enrollment: 7 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** Omeprazole (suspension)
- **OTHER:** Lifestyle Modification

## Key facts

- **NCT ID:** NCT02016820
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02016820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02016820, "Effect of Acid Suppression Medication on Pediatric Microbiome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02016820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*